Medical treatment of early stage and rare histological variants of epithelial ovarian cancer Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, November 04, 2015

Medical treatment of early stage and rare histological variants of epithelial ovarian cancer





ecancermedicalscience - The open access journal from the European Institute of Oncology and the OCEI

 Conclusion
Epithelial ovarian cancer is not a single disease, but a heterogeneous group of neoplasms. Classification on the basis of morphological, immunohystochemical, and genetic analysis and progresses in understanding the molecular background of carcinogenesis contributes to identify specific and unique tumours subtypes with different behaviour, prognosis, and response to chemotherapy.
The current indications for the medical treatment of epithelial ovarian cancer are the same, independently from histological subtypes. It is hoped that the current one size-for-all chemotherapy regimens will evolve into genetic-specific treatments based on molecular markers.

 
Table 2. Characteristics of clear cell, mucinous, and endometrioid ovarian carcinoma in comparison.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.